The FDA has asked manufacturers of GLP-1 agonist medicines used for weight loss to remove warnings that they may cause suicidal thoughts. The request – applying to Novo Nordisk's Wegovy (semaglutide) ...
This report is from the Partnership on AI, a nonprofit that explores the responsible use of artificial intelligence. Members include Amazon, Facebook, Google, DeepMind, Microsoft, IBM, and Apple, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results